(Q38641574)

5 September 2017

Current surgical strategies for malignant pleural mesothelioma (English)

1 reference

5 September 2017

Teruhisa Takuwa

1

1 reference

PubMed ID

26590581

5 September 2017

Seiki Hasegawa

series ordinal

2

1 reference

5 September 2017

21 November 2015

1 reference

5 September 2017

1 reference

5 September 2017

46

1 reference

5 September 2017

8

1 reference

5 September 2017

887-894

1 reference

The management of malignant pleural mesothelioma; single centre experience in 10 years

5 September 2017

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Extrapleural pneumonectomy is the preferred surgical management in the multimodality therapy of pleural mesothelioma: con argument

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Patterns of failure following surgical resection for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Initial analysis of the international association for the study of lung cancer mesothelioma database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Patterns of failure after trimodality therapy for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma in

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Changes in lung function after surgery for mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Extrapleural pneumonectomy for early stage malignant pleural mesothelioma: a harmful procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Surgery for malignant pleural mesothelioma: why, when and what?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Multimodal management of malignant pleural mesothelioma: where are we today?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

The evolution of multimodality therapy for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

A feasibility study evaluating Surgery for Mesothelioma After Radiation Therapy: the "SMART" approach for resectable malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Palliative surgical debulking in malignant mesothelioma. Predictors of survival and symptom control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

Impact of lymph node metastasis on outcome after extrapleural pneumonectomy for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00595-015-1275-3

The MARS feasibility trial: conclusions not supported by data

21 January 2018

1 reference

12 December 2020

Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.

1 reference

12 December 2020

Trimodality therapy for malignant pleural mesothelioma

1 reference

12 December 2020

Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma

1 reference

12 December 2020

Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients

1 reference

12 December 2020

A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma

1 reference

12 December 2020

Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma.

1 reference

12 December 2020

Local and systemic exposure of cisplatin during hyperthermic intrathoracic chemotherapy perfusion after pleurectomy and decortication for treatment of pleural malignancies

1 reference

12 December 2020

The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma

1 reference

12 December 2020

Radical pleurectomy and photodynamic therapy for malignant pleural mesothelioma

1 reference

12 December 2020

Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma

1 reference

12 December 2020

Prospective study on functional results after lung-sparing radical pleurectomy in the management of malignant pleural mesothelioma

1 reference

12 December 2020

Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma

1 reference

12 December 2020

Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma

1 reference

12 December 2020

Indications for pleurectomy in malignant effusion

1 reference

12 December 2020

Pharmacokinetics of Hyperthermic Intrathoracic Chemotherapy following Pleurectomy and Decortication

1 reference

12 December 2020

10.1007/S00595-015-1275-3

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

26590581